Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.

Landman R, Damond F, Gerbe J, Brun-Vezinet F, Yeni P, Matheron S.

AIDS. 2009 Jan 28;23(3):426-8. doi: 10.1097/QAD.0b013e328321305a.

PMID:
19114866
2.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
3.

Sorting through confusing messages: the art of HAART.

Powderly WG.

J Acquir Immune Defic Syndr. 2002 Sep 1;31 Suppl 1:S3-9; discussion S24-5. Review. No abstract available.

PMID:
12218438
4.

Role of the inhibitory quotient in HIV therapy.

Hoefnagel JG, Koopmans PP, Burger DM, Schuurman R, Galama JM.

Antivir Ther. 2005;10(8):879-92. Review.

PMID:
16430193
5.

Update on the human immunodeficiency virus.

Brun-Vézinet F, Charpentier C.

Med Mal Infect. 2013 May;43(5):177-84. doi: 10.1016/j.medmal.2013.03.001. Epub 2013 Apr 28. Review.

PMID:
23628423
6.

[Resistance to antiretroviral drugs].

Tamalet C, Yahi N, Koch N.

Med Trop (Mars). 1997;57(2):121-6. Review. French. No abstract available.

PMID:
9304001
7.

The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.

Gazzola L, Tincati C, Bellistrì GM, Monforte Ad, Marchetti G.

Clin Infect Dis. 2009 Feb 1;48(3):328-37. doi: 10.1086/595851. Review.

8.

Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention.

Kiertiburanakul S, Sungkanuparph S.

Curr HIV Res. 2009 May;7(3):273-8. Review.

PMID:
19442122
9.

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, Schapiro JM.

AIDS. 2008 Oct 18;22(16):2053-67. doi: 10.1097/QAD.0b013e328309520d. Review. No abstract available.

PMID:
18753937
10.

Designing and interpreting HIV noninferiority trials in naive and experienced patients.

Hill A, Sabin C.

AIDS. 2008 May 11;22(8):913-21. doi: 10.1097/QAD.0b013e3282f5556d. Review. No abstract available.

PMID:
18453850
11.

[HIV infection].

Kandel K.

Wien Klin Wochenschr. 2006 Dec;118(23-24 Suppl 3):189-203. Review. German. No abstract available.

PMID:
17674512
12.

Durability of clinical responses to anti-HIV therapies.

Laurence J.

AIDS Read. 2008 Mar;18(3):120-1. Review. No abstract available.

PMID:
18398977
13.

Recent research in HIV infection: Part I.

Boyle BA.

AIDS Read. 2002 Nov;12(11):477-8, 483-5. Review. No abstract available.

PMID:
12494908
14.
16.

[Pathogenesis of HIV infections].

Saksela K.

Duodecim. 1996;112(2):123-9. Review. Finnish. No abstract available.

PMID:
10590618
17.

[Considerations in first line antiretroviral selection for adults].

Ceballos ME.

Rev Chilena Infectol. 2013 Oct;30(5):522-37. doi: 10.4067/S0716-10182013000500010. Review. Spanish. Erratum in: Rev Chilena Infectol. 2013 Dec;30(6):691.

18.
19.
20.

Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review.

Serrano P, Hernández N, Arroyo JA, de Llobet JM, Domingo P.

Clin Infect Dis. 2007 Mar 15;44(6):e57-61. Epub 2007 Feb 8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk